CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-10-03
DOI
10.1186/s12967-022-03641-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle
- (2022) Yu-gang Huang et al. Journal of Translational Medicine
- Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
- (2021) Ruijuan Du et al. Molecular Cancer
- Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
- (2021) Jing Wu et al. CLINICAL CANCER RESEARCH
- Dynamic EMT: a multi‐tool for tumor progression
- (2021) Simone Brabletz et al. EMBO JOURNAL
- CDK1 in Breast Cancer: Implications for Theranostic Potential
- (2020) Sepideh Izadi et al. Anti-Cancer Agents in Medicinal Chemistry
- New perspectives for mitotane treatment of adrenocortical carcinoma
- (2020) S. Puglisi et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis
- (2020) Jinshuai Guo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma
- (2020) Raimunde Liang et al. Frontiers in Endocrinology
- Next-generation therapies for adrenocortical carcinoma
- (2020) Barbara Altieri et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- The regulation of the ZBP1‐NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)
- (2020) Min Zheng et al. IMMUNOLOGICAL REVIEWS
- EMT, MET, Plasticity, and Tumor Metastasis
- (2020) Basil Bakir et al. TRENDS IN CELL BIOLOGY
- The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
- (2020) Parimal Samir et al. Frontiers in Cellular and Infection Microbiology
- Cucurbitacin E Chemosensitizes Colorectal Cancer Cells via Mitigating TFAP4/Wnt/β-Catenin Signaling
- (2020) Peng Yang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)
- (2020) Balaji Banoth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Management of Adrenocortical Carcinoma
- (2019) Sina Jasim et al. Current Oncology Reports
- The role of necroptosis in cancer biology and therapy
- (2019) Yitao Gong et al. Molecular Cancer
- Adrenocortical carcinoma — towards genomics guided clinical care
- (2019) Joakim Crona et al. Nature Reviews Endocrinology
- Pyroptosis: A new frontier in cancer
- (2019) Yuan Fang et al. BIOMEDICINE & PHARMACOTHERAPY
- ZBP1: Innate Sensor Regulating Cell Death and Inflammation
- (2018) Teneema Kuriakose et al. TRENDS IN IMMUNOLOGY
- CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner
- (2018) Remko Prevo et al. CELL CYCLE
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
- (2018) Martin Fassnacht et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pathobiology and genetics of adrenocortical carcinoma
- (2018) James Frederick Henry Pittaway et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
- (2018) Dinoop Ravindran Menon et al. CANCER RESEARCH
- EMT Transition States during Tumor Progression and Metastasis
- (2018) Ievgenia Pastushenko et al. TRENDS IN CELL BIOLOGY
- Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue
- (2017) Zhenjiang Liu et al. JOURNAL OF PINEAL RESEARCH
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy
- (2016) Bowen Ke et al. MEDICINAL RESEARCH REVIEWS
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- Network analysis reveals potential markers for pediatric adrenocortical carcinoma
- (2016) Anurag Kulshrestha et al. OncoTargets and Therapy
- A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer
- (2015) B. H. O'Neil et al. ANNALS OF ONCOLOGY
- Adrenocortical Carcinoma
- (2014) Tobias Else et al. ENDOCRINE REVIEWS
- Nozzle: a report generation toolkit for data analysis pipelines
- (2013) Nils Gehlenborg et al. BIOINFORMATICS
- TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma
- (2013) Meenu Jain et al. ENDOCRINE-RELATED CANCER
- Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling
- (2009) Chunyan Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started